Funds dry up for mRNA vaccines amid US political storm
Venture financing for mRNA vaccines have steeply dropped in 2025, market analysis shows.
Trilink Thematic mRNA WP
Moderna opens UK vaccine manufacturing facility
As US funding falters, mRNA cancer vaccine pioneers face new hurdles
Moderna’s updated Covid-19 vaccine gets Canadian approval
RFK Jr’s mRNA funding halt signals “shift in US public health”
Ethris and Thermo Fisher partner on mRNA solutions
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
Innorna secures dual FDA designations for Wilson’s disease mRNA therapy
